Article
CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase.
Nucleic acids research - 6 Jan 2023
Krysiak Kilannin, Danos Arpad M, Saliba Jason, McMichael Joshua F, Coffman Adam C, Kiwala Susanna, Barnell Erica K, Sheta Lana, Grisdale Cameron J, Kujan Lynzey, Pema Shahil, Lever Jake, Ridd Sarah, Spies Nicholas C, Andric Veronica, Chiorean Andreea, Rieke Damian T, Clark Kaitlin A, Reisle Caralyn, Venigalla Ajay C, Evans Mark, Jani Payal, Takahashi Hideaki, Suda Avila, Horak Peter, Ritter Deborah I, Zhou Xin, Ainscough Benjamin J, Delong Sean, Kesserwan Chimene, Lamping Mario, Shen Haolin, Marr Alex R, Hoang My H, Singhal Kartik, Khanfar Mariam, Li Brian V, Lin Wan-Hsin, Terraf Panieh, Corson Laura B, Salama Yasser, Campbell Katie M, Farncombe Kirsten M, Ji Jianling, Zhao Xiaonan, Xu Xinjie, Kanagal-Shamanna Rashmi, King Ian, Cotto Kelsy C, Skidmore Zachary L, Walker Jason R, Zhang Jinghui, Milosavljevic Aleksandar, Patel Ronak Y, Giles Rachel H, Kim Raymond H, Schriml Lynn M, Mardis Elaine R, Jones Steven J M, Raca Gordana, Rao Shruti, Madhavan Subha, Wagner Alex H, Griffith Malachi, Griffith Obi L
Abstract excerpt
CIViC (Clinical Interpretation of Variants in Cancer; civicdb.org) is a crowd-sourced, public domain knowledgebase composed of literature-derived evidence characterizing the clinical utility of cancer variants. As clinical sequencing becomes more prevalent in cancer management, the need for cancer variant interpretation has grown beyond the capability of any single institution. CIViC contains peer-reviewed,...
Read the complete abstract on PubMed